— Know what they know.
Not Investment Advice

INVA NASDAQ

Innoviva, Inc.
1W: -2.9% 1M: -5.5% 3M: -5.1% YTD: +11.7% 1Y: +18.2% 3Y: +67.5% 5Y: +72.5%
$22.46
+0.26 (+1.17%)
 
Weekly Expected Move ±3.1%
$21 $21 $22 $23 $23
NASDAQ · Healthcare · Biotechnology · Alpha Radar Sell · Power 34 · $1.7B mcap · 69M float · 1.05% daily turnover · Short 44% of daily vol

Revenue Segmentation

By Product / Service

Revenue by Segment (5-Year Trend)

Income Trends

Revenue
$425M +18.5% ▲
5Y CAGR: +4.8%
Gross Profit
$308M -4.5% ▼
5Y CAGR: -1.8%
Operating Income
$164M -1.9% ▼
5Y CAGR: -12.6%
Net Income
$271M +1059.2% ▲
5Y CAGR: +3.9%
EPS (Diluted)
$3.30 +816.7% ▲
5Y CAGR: +10.3%
EBITDA
$384M +348.9% ▲
5Y CAGR: +0.6%

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$392M$331M$310M$359M$425M
YoY Growth+16.4%-15.4%-6.3%+15.5%+18.5%
Cost of Revenue$0$14M$43M$37M$118M
Gross Profit$392M$318M$268M$322M$308M
Gross Margin100.0%95.8%86.3%89.8%72.3%
R&D Expenses$576K$41M$34M$14M$31M
SG&A Expenses$16M$64M$98M$116M$113M
Operating Expenses$17M$354M$154M$155M$144M
Operating Income$375M-$37M$114M$167M$164M
Operating Margin95.7%-11.2%36.7%46.5%38.5%
Interest Expense$19M$16M$19M$22M$17M
Income Before Tax$445M$287M$194M$37M$327M
Tax Expense$76M$67M$14M$14M$56M
Net Income$266M$214M$180M$23M$271M
Net Margin67.8%64.6%57.9%6.5%63.8%
EPS (Diluted)$2.87$2.37$2.20$0.36$3.30
EBITDA$464M$308M$235M$85M$384M
Shares Outstanding94M95M87M74M85M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms